WebDr. Caforio leads the Bristol-Myers Squibb Company's pharmaceutical business in the U.S. He served as Chief Commercial Officer at Medarex, Inc. Dr. Caforio served as the President of U.S. Pharmaceuticals at Bristol Myers Squibb Company since October 2011. WebJul 24, 2024 · “Despite significant advancements in oncology research for adults in recent years, treatment options continue to be limited for pediatric patients with metastatic melanoma,” said Chris Boerner, PhD, president and head of U.S. commercial operations, Bristol-Myers Squibb.
Healthcare Industry Innovators and Workplace Equality Advocates ...
WebOne of our eight People and Business Resource Groups (PBRGs), B-NOW’s mission of prioritizing gender diversity and inclusion is central to our work and culture; ensuring the contributions of women at Bristol Myers Squibb are heard, valued, rewarded and – crucially – incorporated into the work we do for patients. WebView the profiles of professionals named "Chris Boerner" on LinkedIn. There are 10+ professionals named "Chris Boerner", who use LinkedIn to exchange information, ideas, … ohh come on
Announcing the 2024 HBA Central New Jersey Chapter Board of …
WebD X o v v o v K Ç ÇE Á z } l. ] v o P ] vD µ ] o ] ( } v ] D X D v o ] > v } À D Ç o v WebAug 28, 2024 · Bristol-Myers Squibb Company (NYSE:BMY) today announced that Christopher Boerner, Ph.D., has been appointed executive vice president and chief commercial officer, effective immediately. Boerner succeeds Murdo Gordon, who departed the company on August 3, 2024, to pursue another opportunity. WebAug 28, 2024 · Bristol-Myers Squibb Company (NYSE:BMY) today announced that Christopher Boerner, Ph.D., has been appointed executive vice president and chief … ohh crabe